Dr. Dr Tay Ze Yun

• Head and neck surgery
• Thyroid Surgery
• Parathyroid Surgery
• Neck lumps evaluation
• Sleep and sinus surgery

• Transoral laser surgery
• Minimally invasive head and neck surgery

Dr Tay graduated from the National University of Singapore and received his medical degree from the Yong Loo Lin School of Medicine in 2008. He subsequently joined the Singhealth Otolaryngology Residency Programme as part of the inaugural batch of residents and completed his specialist training in 2016.

In pursue of his sub-speciality interest in Head and Neck Surgery, he completed the two-year Singhealth Duke- NUS Head and Neck Surgical Oncology Fellowship program (2016 – 2018). This fellowship was concurrent to his role as Associate Consultant in the ENT department during that two years, for which he was performing general ENT practice.

He was subsequently awarded the MOH Health Manpower Development Plan (HMDP) award in 2018 to pursue a surgical fellowship in advanced head and neck surgical oncology at the world-renown Chang Gung Memorial Hospital, one of the largest healthcare institution in Taiwan and which manages one of the highest numbers of oral cavity cancer patients worldwide.

Following his overseas training, Dr Tay also completed the International Federation of Head and Neck Oncologic Societies (IFHNOS) fellowship and graduated with Honors in 2020.

Prior to private practice, he served as Consultant ENT Head and Neck surgeon with the Department of Otorhinolaryngology – Head and Neck Surgery at both Sengkang General Hospital and Singapore General Hospital. He was also concurrently the service chief of Singhealth Duke-NUS Head & Neck Centre for SKH, leading a multidisciplinary team for the provision and development of the sub-specialty services at the site. He was visiting Consultant to the National Cancer Centre Singapore and KK Women & Children Hospital as well.

Apart from his clinical duties, he was actively involved in medical education, serving as Undergraduate Education Director for the department and being appointed as assistant professor to both NUS Yong Loo Lin School of Medicine and Duke-NUS. Of note, under his stewardship, the department was awarded the prestigious NUS Clinical Training Excellence Award on consecutive years from 2019 to 2023.

1. American Association Otolaryngology – Head and Neck Surgery Meeting 2015 (Dallas, Texas, USA) –Endoscopic Nasopharyngectomy for Recurrent NPC
2. Taiwan Society of Otorhinolaryngology Head and Neck Surgery 105th Meeting 2018 – The prediction value of the systemic inflammation score for oral cavity squamous cell carcinoma
3. 6th Asian Society of Head & Neck Oncology Meeting, ASHNO 2019 – Multiple Concomitant Oral Cavity Cancers: Incidence, Management and Outcomes
4. 2019 International Conference & 13th Annual Meeting of Taiwan Head and Neck Society (endorsed by AAOHNSF) – Multiple Concomitant Oral Cavity Cancers: Incidence, Management and Outcomes
5. Tsung-You Tsai, Ze Yun Tay, Kai-Ping Chang, Yu-Tung Huang. In Response to A Nomogram to Predict Osteoradionecrosis in Oral Cancer After Marginal Mandibulectomy and Radiotherapy. Laryngoscope. 2019 Oct;129(10):E344.doi: 10.1002/lary.28092. Epub 2019 May 31.
6. Lin CY, Fan KH, Lee LY, Hsueh C, Yang LY, Ng SH, Wang HM, Hsieh CH, Lin CH, Tsao CK, Kang CJ, Fang TJ, Lee LA, Huang SF, Chang KP, Yen TC, Tay ZY, Wen YW, Lee SR, Liao CT. Precision Adjuvant Therapy Based on Detailed Pathological Risk Factors for Resected Oral Cavity Squamous Cell Carcinoma: Long Term Outcome Comparison of CGMH and NCCN Guidelines. Int J Radiat Oncol Biol Phys.2019 Sep 6. pii: S0360-3016(19)33747-2. doi: 10.1016/j.ijrobp.2019.08.058.
7. ZY Tay, P Padua, SF Tai, YL Huang, CL Hsu, NM Tsang, KP Chang. Long-term Treatment and Survival Outcomes of Salivary Adenoid Cystic Carcinoma. International Journal of Head and Neck Science 3(4): 208-218, 2019 doi:10.6696/IJHNS.201912_3(4).0004
8. Kuang-Hsu Lien, Paula Francezca C Padua, Ze Yun Tay, Huang-Kai Kao, Shao-Yu Hung, Yenlin Huang, Ngan-Ming Tsang, Kai-Ping Chang. Influence of Hyperglycemia on Treatment Outcomes of Oral Cavity Squamous Cell Carcinoma. J Oral Maxillofac Surg. 2020 Jun;78(6):935-942.doi: 10.1016/j.joms.2020.01.018. Epub 2020 Jan 23.
9. Ze Yun Tay, Huang-Kai Kao, Kuang-Hsu Lien, Shao-Yu Hung, Yenlin Huang, Ngan-Ming Tsang, Kai-Ping Chang. The impact of preoperative glycated hemoglobin levels on outcomes in oral squamous cell carcinoma. Oral Dis. 2020 May 19. doi: 10.1111/odi.13433.
10. Pei Yuan Fong, Ze Yun Tay, Rui Ya Soh, Stephanie Man Chung Fook , Hui Hua Li , Chu Qin Phua. Should mild OSA be treated? – A systematic review from the standpoint of disease progression. J Laryngol Otol. 2022 Nov 16;1-24. doi: 10.1017/S0022215122002419.

1. Member of Royal College of Physicians and Surgeons of Glasgow
2. Member of Singapore Medical Association
3. Member of Society of Otorhinolaryngology-Head and Neck Surgery Singapore
4. Fellow of Academy of Medicine, Singapore
5. Member, Asia Pacific Society of Thyroid Surgery
6. Member, New Voice Club Advisory Committee, Singapore Cancer Society